Usefulness of Elobixibat in Patients With Chronic Constipation After Cholecystectomy
Authors:
Open Access
- 18 August 2024
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 16 (8) , e67132
Abstract
Background: There have been reports that elobixibat improves bowel movements in patients with chronic constipation. However, no studies have been conducted to date to examine bowel movements after the administration of elobixibat in patients with chronic constipation in terms of the presence or absence of the gallbladder. In this study, we examined the frequency of bowel movements and stool forms in patients with gallbladders and post-cholecystectomy patients before and after the administration of elobixibat for chronic constipation. Methods: Elobixibat 10 mg was administered to treat chronic constipation in 40 patients with gallbladders and 18 patients who underwent cholecystectomy. The frequencies of bowel movements one week before and after elobixibat administration were compared between the two groups, using the Bristol Stool Form Scale (BSFS). Results: No significant difference in patient background with or without cholecystectomy was noted between the groups. In patients with gallbladders, the pre-dosing mean frequency of bowel movements was 2.389 +/- 0.502 with BSFS of 2.179 +/- 0.721 and the post-dosing mean frequency of bowel movements was 4.308 +/- 1.151 with BSFS of 3.718 +/- 1.521, indicating significant improvement in bowel movements (p < 0.001). In post-cholecystectomy patients, the pre-dosing mean frequency of bowel movements was 2.389 +/- 0.502 with BSFS of 2.222 +/- 0.647 and the post-dosing mean frequency of bowel movements was 4.222 +/- 1.734 with BSFS of 3.333 +/- 1.237, indicating significant improvement in bowel movements (p < 0.001). No significant difference in bowel movements was noted between patients with or without the gallbladder. Conclusions: Elobixibat is useful in improving the bowel movements of patients with chronic constipation. No significant difference was noted in the improvement of bowel movements due to cholecystectomy. It was suggested that even post-cholecystectomy patients could obtain therapeutic effects similar to patients with gallbladders.Keywords
This publication has 25 references indexed in Scilit:
- Constipation and risk of death and cardiovascular eventsAtherosclerosis, 2019
- Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trialThe Lancet Gastroenterology & Hepatology, 2018
- Determining an optimal clinical dose of elobixibat, a novel inhibitor of the ileal bile acid transporter, in Japanese patients with chronic constipation: a phase II, multicenter, double-blind, placebo-controlled randomized clinical trialJournal of Gastroenterology, 2017
- Bowel DisordersGastroenterology, 2016
- Defecation frequency and cardiovascular disease mortality in Japan: The Ohsaki cohort studyAtherosclerosis, 2016
- The role of the gallbladder in humansRevista de Gastroenterología de México, 2013
- Impact of Persistent Constipation on Health-Related Quality of Life and Mortality in Older Community-Dwelling WomenAmerican Journal of Gastroenterology, 2013
- Efficacy and Safety of Lubiprostone in Patients with Chronic ConstipationDigestive Diseases and Sciences, 2009
- Functional Bowel DisordersGastroenterology, 2006
- Duodenogastric reflux following cholecystectomy in the dog: role of antroduodenal motor functionAlimentary Pharmacology & Therapeutics, 2001